Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€13.06
26.03.24
€20.00
21.03.25
-18.95%
01.09.24

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€39.49
31.08.23
€55.34
31.08.24
46.16%
01.09.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.60
08.08.23
€228.30
08.08.24
46.56%
09.08.24

Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
08.08.23
€1.83
08.08.24
-75.48%
09.08.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.60
04.08.23
€244.57
04.08.24
44.72%
05.08.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.00
04.08.23
€217.73
04.08.24
45.24%
05.08.24

buy
United Therapeutics

Start price
Target price
Perf. (%)
€212.40
03.08.23
€290.24
03.08.24
32.72%
04.08.24

buy
United Therapeutics

Start price
Target price
Perf. (%)
€219.60
03.08.23
€274.20
03.08.24
28.37%
04.08.24

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€94.60
02.08.23
€137.10
02.08.24
47.73%
03.08.24

buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€236.00
25.07.23
€247.47
25.07.24
50.85%
26.07.24

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€33.15
19.05.23
€40.00
19.05.24
54.24%
20.05.24

Could be worthwhile Investment >10% per year
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€3.03
03.04.23
€2.76
03.04.24
-64.27%
04.04.24

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€89.90
30.03.23
€120.95
30.03.24
47.22%
01.04.24

Invitae Corp

Start price
Target price
Perf. (%)
€1.30
11.03.23
€0.40
11.03.24
-93.65%
12.03.24

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.32
28.02.23
€1.88
28.02.24
-50.72%
29.02.24

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€0.88
25.01.24
€1.30
25.01.25
143.18%
19.02.24

Could be very worthwhile Investment >20% year
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€1.19
20.01.24
€1.00
20.01.25
-25.08%
03.02.24

buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€33.09
30.10.21
€45.00
31.12.23
94.65%
05.08.22

Could be very worthwhile Investment >20% year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€9.23
09.11.21
€7.00
31.12.23
-56.18%
28.06.22

Could be very worthwhile Investment >20% year
Invitae Corp

Start price
Target price
Perf. (%)
€20.09
09.11.21
€17.00
31.12.23
-23.92%
01.12.21

Could be very worthwhile Investment >20% year
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€91.00
24.09.20
€145.00
04.11.21
114.29%
05.11.21

Could be worthwhile Investment >10% per year
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€64.30
31.08.20
€66.00
04.11.21
55.52%
05.11.21

buy
Ironwood Pharmaceuticals

Start price
Target price
Perf. (%)
€8.95
25.08.20
€10.00
04.11.21
15.08%
05.11.21

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€121.45
21.08.20
€130.00
04.11.21
19.06%
05.11.21